Glen Eagle Advisors, LLC Pfizer Inc Transaction History

Glen Eagle Advisors, LLC

$593 Billion
Q3 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 24,066 shares of PFE stock, worth $634,379. This represents 0.12% of its overall portfolio holdings.

Number of Shares

24,066

Previous 26,968 10.76%

Holding current value

$634,379

Previous $755 Million 7.7%

% of portfolio

0.12%

Previous 0.14%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $80,385 - $91,093	-2,902 Reduced 10.76%	24,066 $696 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $465,945 - $546,001	18,446 Added 216.45%	26,968 $755 Million
Q1 2024 Jul 03, 2024	BUY	$25.89 - $29.73 $982,447 - $1.13 Million	37,947 New	37,947 $1.05 Billion
Q4 2023 Aug 13, 2024	SELL	$26.13 - $33.94 $203,213 - $263,951	-7,777 Reduced 15.25%	43,207 $1.24 Billion
Q3 2023 Aug 13, 2024	SELL	$32.09 - $37.51 $8,760 - $10,240	-273 Reduced 0.53%	50,984 $1.69 Billion
Q2 2023 Aug 13, 2024	BUY	$36.12 - $41.79 $187,751 - $217,224	5,198 Added 11.29%	51,257 $1.88 Billion
Q1 2023 Aug 13, 2024	BUY	$39.39 - $51.28 $100,326 - $130,610	2,547 Added 5.85%	46,059 $1.88 Billion
Q4 2022 Aug 13, 2024	SELL	$41.75 - $54.5 $18,411 - $24,034	-441 Reduced 1.0%	43,512 $2.23 Billion
Q3 2022 Aug 13, 2024	SELL	$43.76 - $53.42 $377,823 - $461,228	-8,634 Reduced 16.42%	43,953 $1.92 Billion
Q2 2022 Aug 13, 2024	BUY	$46.53 - $55.17 $256,566 - $304,207	5,514 Added 11.71%	52,587 $2.76 Billion
Q1 2022 Aug 13, 2024	SELL	$45.75 - $56.69 $4,529 - $5,612	-99 Reduced 0.21%	47,073 $2.44 Billion
Q4 2021 Aug 13, 2024	SELL	$41.32 - $61.25 $67,806 - $100,511	-1,641 Reduced 3.36%	47,172 $2.79 Billion
Q3 2021 Aug 13, 2024	BUY	$39.25 - $50.42 $107,388 - $137,949	2,736 Added 5.94%	48,813 $2.1 Billion
Q2 2021 Aug 13, 2024	BUY	$35.91 - $40.68 $38,782 - $43,934	1,080 Added 2.4%	46,077 $1.8 Billion
Q1 2021 Aug 13, 2024	BUY	$33.49 - $37.77 $94,609 - $106,700	2,825 Added 6.7%	44,997 $1.64 Billion
Q4 2020 Aug 13, 2024	BUY	$33.47 - $42.56 $141,410 - $179,816	4,225 Added 11.13%	42,172 $1.55 Billion
Q3 2020 Aug 13, 2024	BUY	$31.75 - $37.25 $151,225 - $177,421	4,763 Added 12.91%	41,649 $1.53 Billion
Q2 2020 Aug 13, 2024	BUY	$30.12 - $36.54 $590,803 - $716,732	19,615 Added 113.57%	36,886 $1.21 Billion
Q1 2020 Aug 13, 2024	BUY	$27.03 - $38.62 $108,390 - $154,866	4,010 Added 30.24%	17,271 $564 Million
Q4 2019 Aug 13, 2024	BUY	$32.92 - $37.36 $74,925 - $85,031	2,276 Added 20.72%	13,261 $520 Million
Q3 2019 Aug 13, 2024	BUY	$32.49 - $42.13 $6,270 - $8,131	193 Added 1.79%	10,985 $395 Million
Q2 2019 Aug 13, 2024	BUY	$36.98 - $41.52 $3,180 - $3,570	86 Added 0.8%	10,792 $468 Million
Q1 2019 Aug 13, 2024	SELL	$37.5 - $41.2 $1.02 Million - $1.12 Million	-27,241 Reduced 71.79%	10,706 $455 Million
Q4 2018 Aug 13, 2024	BUY	$38.47 - $43.86 $7,001 - $7,982	182 Added 1.84%	10,085 $440 Million
Q3 2018 Aug 13, 2024	SELL	$34.47 - $41.81 $5,170 - $6,271	-150 Reduced 1.49%	9,903 $436 Million
Q2 2018 Aug 13, 2024	SELL	$32.98 - $35.16 $6.61 Million - $7.05 Million	-200,479 Reduced 95.22%	10,053 $365 Million
Q1 2018 Aug 14, 2024	SELL	$31.91 - $37.02 $938,951 - $1.09 Million	-29,425 Reduced 77.54%	8,522 $302 Million
Q1 2018 Aug 13, 2024	BUY	$31.91 - $37.02 $6.47 Million - $7.51 Million	202,817 Added 2628.87%	210,532 $302 Million
Q4 2017 Aug 13, 2024	BUY	$33.26 - $35.29 $13,802 - $14,645	415 Added 5.68%	7,715 $279 Million
Q3 2017 Aug 13, 2024	SELL	$31.0 - $34.15 $950,057 - $1.05 Million	-30,647 Reduced 80.76%	7,300 $261 Million
Q2 2017 Aug 12, 2024	BUY	N/A	180 Added 1.95%	9,419 $316 Million
Q1 2017 Aug 12, 2024	SELL	N/A	-222 Reduced 2.35%	9,239 $317 Million
Q4 2016 Aug 12, 2024	SELL	N/A	-28,486	9,461 $307 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Pfizer Inc Transaction History